{"title":"Corrigendum to ‘Sinigrin improves cerebral ischaemia-reperfusion injury by inhibiting the TLR4 pathway-mediated oxidative stress’","authors":"","doi":"10.1111/cbdd.14524","DOIUrl":null,"url":null,"abstract":"<p>Corrigendum to ‘Sinigrin improves cerebral ischaemia-reperfusion injury by inhibiting the TLR4 pathway-mediated oxidative stress.’ Chem Biol Drug Des. 2024 Feb;103(2):e14480. doi: 10.1111/cbdd.14480</p><p>Shenglong Guo<sup>1</sup>, Qi Lei<sup>1</sup>, Qian Yang<sup>1</sup>, Ruili Chen<sup>1</sup></p><p><sup>1</sup>Department II of Neurology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, P.R. China</p><p>The above article was published with several errors in the author information.</p><p>Qi Lei is not co-first author as listed.</p><p>Qian Yang is not a co-correspondence author.</p><p>The correct correspondence details are</p><p>\n <b>Correspondence</b>\n </p><p>Ruili Chen, Department II of Neurology, Shaanxi Provincial People's Hospital, No. 256, Youyi West Road, Xi'an, 710068, Shaanxi, P.R. China.</p><p>Email: <span>[email protected]</span></p><p>The authors would like to apologize for any inconvenience caused.</p>","PeriodicalId":143,"journal":{"name":"Chemical Biology & Drug Design","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cbdd.14524","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Biology & Drug Design","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cbdd.14524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Corrigendum to ‘Sinigrin improves cerebral ischaemia-reperfusion injury by inhibiting the TLR4 pathway-mediated oxidative stress.’ Chem Biol Drug Des. 2024 Feb;103(2):e14480. doi: 10.1111/cbdd.14480
Shenglong Guo1, Qi Lei1, Qian Yang1, Ruili Chen1
1Department II of Neurology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, P.R. China
The above article was published with several errors in the author information.
Qi Lei is not co-first author as listed.
Qian Yang is not a co-correspondence author.
The correct correspondence details are
Correspondence
Ruili Chen, Department II of Neurology, Shaanxi Provincial People's Hospital, No. 256, Youyi West Road, Xi'an, 710068, Shaanxi, P.R. China.
Email: [email protected]
The authors would like to apologize for any inconvenience caused.
期刊介绍：
Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
